an additional 15 asymptomatic patients who were receiving high doses of oral niacin ( 1.0-6.0 g daily ) for the treatment of hypercholesterolemia were evaluated for evidence of subclinical macular disease .
C0027996
niacin
C0020443
hypercholesterolemia